GENE THERAPY CMC AND QUALITY CONTROL

Are you finishing strong in cell therapy manufacturing? Tackling your final fill and finish challenges with automation

Cell & Gene Therapy Insights 2021; 7(9), 1161

10.18609/cgti.2021.156

Published: 4 November 2021
Webinar Digest
Dalip Sethi, Annie Cunningham

Dalip Sethi

Manager, Senior Scientist at Terumo BCT

Dalip Sethi, is the Director of Scientific Affairs, and currently serves as Scientific and Clinical Development Lead for the cell therapy technologies portfolio at Terumo BCT. Prior to that, Dalip was engaged in the development of technologies and methods for use in cell therapy applications. He has authored multiple scientific publications, and is co-inventor on several patents.

Annie Cunningham

Laboratory Scientist, Terumo BCT

Annie Cunningham, is a Laboratory Scientist at Terumo BCT, were she is leading projects on the quantum cell expansion system, and the FINIA fill and finish system. Annie spent most of her career in the biotechnology industry, before shifting focus into immunotherapy, and contributing to the development of the CAR T program. She continued her research into the human immune system at the University of Colorado.

View pdf


You can view the summary PDF here


Authorship & Conflict of Interest

Contributions: All named authors take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Acknowledgements: None.

Disclosure and potential conflicts of interest: The authors are both employees of Terumo Blood and Cell Technologies. D Sethi is an active member of ISCT-PPD committee and on the steering committee for Catapult PAT consortium. The authors declare that they have no other conflicts of interest.

Funding declaration: The author received no financial support for the research, authorship, and/or publication of this article.

Article & copyright information

Copyright: Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.

Attribution: Copyright © 2021 Terumo BCT. Published by Cell and Gene Therapy Insights under Creative Commons License Deed CC BY NC ND 4.0.

Article source: Article based on a webinar which can be found here.

Webinar recorded: Jul 21 2021; Revised manuscript received: Sep 30 2021; Publication date: Nov 9 2021.

This article is part of the Gene therapy CMC and quality control spotlight